Construction Underway on BioVectra’s mRNA Biomanufacturing Facility

Construction is well underway on BioVectra’s new mRNA biomanufacturing facility in Charlottetown, Prince Edward Island (PEI) in Canada.

The Canadian pharma and biotech contract development and manufacturing organization (CDMO) with global services had announced plans for the $79.6 million state-of-the-art mRNA vaccine and biomanufacturing facility, making it one of the first in the country. The cutting-edge plant will be dedicated to the manufacturing of mRNA vaccines and therapeutics.